Human medicines European public assessment report (EPAR): Vazkepa, icosapent ethyl, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Vazkepa, icosapent ethyl, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Questions and Answers on the Joint Controllership Arrangement and data protection matters related to the use of the Clinical Trials Information System

Questions and Answers on the Joint Controllership Arrangement and data protection matters related to the use of the Clinical Trials Information System

Human medicines European public assessment report (EPAR): Xerava, eravacycline, Date of authorisation: 20/09/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Xerava, eravacycline, Date of authorisation: 20/09/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Date of authorisation: 22/08/2014, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Date of authorisation: 22/08/2014, Revision: 23, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness